More Than Half Of Erectile Dysfunction Drugs Sold Online In Japan Fakes
This article was originally published in PharmAsia News
Executive Summary
A survey revealed that over 55 percent of erectile dysfunction drugs sold over the internet targeting Japanese customers are counterfeits. Conducted from December 2008 to April 2009, the survey is a joint project of four drug makers of Viagra (sildenafil), Levitra (vardenafil) and Cialas (tadalafil): Pfizer, Bayer Yakuhin, Eli Lilly Japan and Nippon Shinyaku. The companies analyzed drug samples ordered from 30 websites that are based in domestic locations and 30 sites in Thailand targeting Japanese customers. The results show that the majority of the counterfeits are imports from Thailand, accounting for 67.8 percent, and fake ED drugs purchased inside Japan account for 43.6 percent. The quality of the counterfeits also vary; some contain more or less active ingredients and others have no active ingredients at all. (Click here for more - Japanese language
You may also be interested in...
Ultrahuman Expands Wearable Medtech Production Into US After $35M Funding Round
Firm operating in London, India and United Arab Emirates says its “Ultra Factory” will open in Indiana within the next six months with end-to-end production based on its operational facility in India.
Cochlear’s Osia System Receives Expanded FDA Clearance For Use In Younger Children
Kids ages 5 and up now can benefit from Cochlear’s Osia implant and sound processor, indicated for hearing loss, mixed hearing loss and single-sided sensorineural deafness.
MAISI: Navigating The 'Valley Of Death' In Medtech Research Translation
Translating research from proof of concept to clinical investigations is a difficult hurdle to overcome. To succeed, researchers need to design their technology for industrial standard manufacturing early on, Anne Vanhoestenberghe, director for the Manufacture of Active Implants and Surgical Instruments (MAISI), told Medtech Insight.